Evidence map›Paper›PMID 37774088›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2024

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).

Bruce Albala, Eline Appelmans, Ramona Burress, Susan De Santi, Theresa Devins, Gregory Klein, Veronika Logovinsky, Gerald P Novak, Kim Ribeiro, Mark E Schmidt and 9 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. ADNI Biomarker Core: A review of progress since 2004 and future challenges.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  4. Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  5. The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging Initiative.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  6. Data sharing as the foundation of discovery: ADNI and breakthroughs in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 3 countries.

Bruce AlbalaEisai Inc., Nutley, New Jersey, USA.
Eline AppelmansFoundation for the National Institutes of Health, North Bethesda, Maryland, USA.
Ramona BurressJanssen Research & Development, LLC, Titusville, New Jersey, USA.
Susan De SantiEisai Inc., Nutley, New Jersey, USA.
Theresa DevinsEisai Inc., Nutley, New Jersey, USA.
Gregory KleinF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Veronika LogovinskyEisai Inc., Nutley, New Jersey, USA.
Gerald P NovakJanssen Research & Development, LLC, Titusville, New Jersey, USA.
Kim RibeiroAbbVie Inc., North Chicago, Illinois, USA.
Mark E SchmidtJanssen Research & Development, Beerse, Belgium.
Adam J SchwarzTakeda Pharmaceutical Company Ltd., Cambridge, Massachusetts, USA.
David ScottClario, San Mateo, California, USA.
Sergey ShcherbininEli Lilly and Company, Indianapolis, Indiana, USA.
Eric SiemersCogstate Ltd, New Haven, Connecticut, USA.
Alessio TravagliaFoundation for the National Institutes of Health, North Bethesda, Maryland, USA.
Christopher J WeberAlzheimer's Association, Chicago, Illinois, USA.
Leah WhiteFoundation for the National Institutes of Health, North Bethesda, Maryland, USA.
Julie Wolf-RoddaFoundation for the National Institutes of Health, North Bethesda, Maryland, USA.
Aparna VasanthakumarAbbVie Inc., North Chicago, Illinois, USA.
Eisai (United States) · USFoundation for the National Institutes of Health · USAbbVie (United States) · USJanssen (United States) · USAlzheimer's Association · USClarion University · USEli Lilly (United States) · USJanssen (Belgium) · BERoche (Switzerland) · CHTakeda (United States) · USUniversity of New Haven · US

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MONICA G. RIVERA-MINDT · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904NIBIB NIH HHSNIH HHS U01 AG024904
6 · The paper itself

Abstract

The Alzheimer's Disease Neuroimaging Initiative (ADNI) Private Partners Scientific Board (PPSB) encompasses members from industry, biotechnology, diagnostic, and non-profit organizations that have until recently been managed by the Foundation for the National Institutes of Health (FNIH) and provided financial and scientific support to ADNI programs. In this article, we review some of the major activities undertaken by the PPSB, focusing on those supporting the most recently completed National Institute on Aging grant, ADNI3, and the impact it has had on streamlining biomarker discovery and validation in Alzheimer's disease. We also provide a perspective on the gaps that may be filled with future PPSB activities as part of ADNI4 and beyond. HIGHLIGHTS: The Private Partners Scientific board (PPSB) continues to play a key role in enabling several Alzheimer's Disease Neuroimaging Initiative (ADNI) activities. PPSB working groups have led landscape assessments to provide valuable feedback on new technologies, platforms, and methods that may be taken up by ADNI in current or future iterations.

Indexed as

Alzheimer DiseaseBiomedical ResearchBlood Coagulation FactorsBiomarkersHumansNeuroimagingBiomarkersBlood Coagulation Factorsprothrombin complex concentratesAlzheimer's disease clinical trialsAlzheimer's Disease Neuroimaging Initiativebiomarkersneuroimaging

Identifiers

PMID37774088
PMCPMC10843521
OpenAlexW4387164548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.